This study will examine the feasibility of using a mobile ABMT application as a treatment modality in the Pediatric Multiple Sclerosis population. Participants will be asked to undergo one hour-long baseline evaluation, followed by at-home ABMT application sessions. Subjects will complete online REDCap or MyCap surveys weekly and at the end of the study.
Age 12-24 years Confirmed Diagnosis of Multiple Sclerosis with onset < 17 years and 11 months (defined by the 2013 International Pediatric MS Study Group (IPMSSG) criteria (Krupp, Tardieu, Amato, Banwell, Chitnis, Dale, Ghezzi, Hintzen, Kornberg, Pohl, Rostasy, Tenembaum, Wassmer, & Sclerosis, 2013) and the 2010 McDonald criteria (Polman et al., 2011).) Followed at NYU Multiple Sclerosis Comprehensive Care Center Access to a mobile device with iOS (devices will be provided to subjects if this criteria is not met, see section 4.4) Active or concurrently enrolled in the ongoing US Network of Pediatric MS Centers Study Consortium
Exclusion Criteria:
Previous report of an IQ < 70 Wide-Range Achievement Test-Fourth Edition (Wilkerson, 2006) Reading Subtest standard score <85 Non-English speaking, learned English in the past three years, or learned English after the age of 12 years Not willing to comply with all study procedures Insufficient visual and motor ability to operate the intervention and assessments
